Skip to Content


In the US, Zelapar (selegiline systemic) is a member of the following drug classes: dopaminergic antiparkinsonism agents, monoamine oxidase inhibitors and is used to treat Parkinson's Disease.

US matches:

Ingredient matches for Zelapar


Selegiline hydrochloride (a derivative of Selegiline) is reported as an ingredient of Zelapar in the following countries:

  • United States

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.